人工关节置换术后假体无菌性松动的早期诊断
|
摘要
人工关节置换术(TJA)是临床治疗各种终末期关节疾病最为常用且有效的方法,随着手术量的增大,其并发症越来越得到人们的重视,尤其是假体无菌性松动,严重影响了假体的使用寿命,需要进一步行翻修手术。因此,如何提高假体无菌性松动早期诊断的敏感性和特异性,将对评估假体磨损状态、延长假体寿命以及改善患者生活质量有重要意义。在此,本文对人工关节假体无菌性松动的早期诊断进展作一综述。
Total joint arthroplasty( TJA) is the most common and effective treatment for a variety of end-stage joint-related diseases. Complication rate,especially prostheses aseptic loosening,rises. It seriously affects prostheses survival time,thus,revision surgery is inevitable. Increasing the sensitivity and specificity of diagnosis of aseptic loosening will be important to evaluate the prostheses wear,to extend the prostheses life and to improve the patients' life quality. This article reviewed the advancements of early diagnoses of aseptic loosening.
Total joint arthroplasty( TJA) is the most common and effective treatment for a variety of end-stage joint-related diseases. Complication rate,especially prostheses aseptic loosening,rises. It seriously affects prostheses survival time,thus,revision surgery is inevitable. Increasing the sensitivity and specificity of diagnosis of aseptic loosening will be important to evaluate the prostheses wear,to extend the prostheses life and to improve the patients' life quality. This article reviewed the advancements of early diagnoses of aseptic loosening.
引文
[1] Pedersen AB, Johnsen SP, Overgaard S, et al. Total hip arthroplasty in Denmark:incidence of primary operations and revisions during 1996-2002 and estimated future demands[J].Acta Orthop,2005,76(2):182-189.
[2]牛舜,孔令擘,杨重飞,等.阿仑膦酸钠局部释放对假体周围骨溶解的抑制作用[J].中华创伤骨科杂志,2009,11(11):1052-1057.
[3] Niu S, Cao X, Zhang Y, et al. The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debrisinduced peri-implant high bone turnover[J]. J Surg Res,2013,179(1):e107-e115.
[4]吕丹,孙明林.人工髋关节置换后假体无菌性松动的因素及其防治[J].中国组织工程研究与临床康复,2009,13(13):2553-2556.
[5]魏慧,田京.人工关节无菌性松动的早期诊断[J].中国组织工程研究与临床康复,2011,15(4):709-713.
[6]翁习生,翟吉良,林进,等.初次全髋关节置换术后5年以上随访结果[J/CD].中华关节外科杂志(电子版),2011,05(5):561-566.
[7] Lee YH,Park KK,Song HT,et al. Metal artefact reduction in gemstone spectral imaging dual-energy CT with and without metal artefact reduction software[J]. Eur Radiol,2012,22(6):1331-1340.
[8] Van Slambrouck K,Nuyts J. Metal artifact reduction in computed tomography using local models in an image block-iterative scheme[J]. Med Phys,2012,39(11):7080-7093.
[9] Garcia-Cimbrelo E, Tapia M, Martin-Hervas C. Multislice computed tomography for evaluating acetabular defects in revision THA[J]. Clin Orthop Relat Res,2007,463(463):138-143.
[10] Sofka CM. Optimizing techniques for musculoskeletal imaging of the postoperative patient[J]. Radiol Clin North Am,2006,44(3):323-329.
[11] Granchi D,Amato I,Battistelli L,et al. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles[J]. Biomaterials,2005,26(15):2371-2379.
[12] L@hdeoja T,Pajarinen J,Kouri VP,et al. Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals?[J]. J Orthop Res,2010,28(2):184-190.
[13] Crotti TN,Smith MD,Findlay DM,et al. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss:expression of receptor activator NFkappaB,RANK ligand and osteoprotegerin[J]. Biomaterials,2004,25(4):565-573.
[14] Koulouvaris P,Ly K,Ivashkiv LB,et al. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis[J]. J Orthop Res,2008,26(1):106-116.
[15] Granchi D, Pellacani A, Spina M, et al. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis[J]. J Bone Joint Surg Am,2006,88(7):1501-1509.
[16] Savarino L,Granchi D,Cenni E,et al. Systemic cross-linked Nterminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty[J]. J Bone Joint Surg Br,2005,87(4):571-576.
[17] Kauther MD,Zimmermann C,Bachmann H,et al. Biochemical markers of particle induced osteolysis in C57BL/6 mice[J]. Clin Chem Lab Med,2010,48(11):1641-1646.
[18] Streich NA,Gotterbarm T,Jung M,et al. Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty[J]. Int Orthop,2009,33(1):77-82.
[19] Landgraeber S,L`er F,Heep H,et al. Tartrate-resistant acid phosphatase 5b and C-terminal telopeptides of type I collagen as markers for diagnosis of aseptic loosening after total hip replacement[J]. Arch Orthop Trauma Surg,2010,130(4):441-445.
[20] Hundrif-Haspl Z,Pecina M,Haspl M,et al. Plasma cytokines as markers of aseptic prosthesis loosening[J]. Clin Orthop Relat Res,2006,453(453):299-304.
[21] Shanbhag AS, Kaufman AM, Hayata K, et al. Assessing osteolysis with use of high-throughput protein chips[J]. J Bone Joint Surg Am,2007,89(5):1081-1089.
[22] Reinartz P,Mumme T,Hermanns B,et al. Radionuclide imaging of the painful hip arthroplasty:positron-emission tomography versus triple-phase bone scanning[J]. J Bone Joint Surg Br,2005,87(4):465-470.
[23] Mayer-Wagner S,Mayer W,Maegerlein S,et al. Use of 18FFDG-PET in the diagnosis of endoprosthetic loosening of knee and hip implants[J]. Arch Orthop Trauma Surg,2010,130(10):1231-1238.
[24]贾宇东,刘又文,张晓东,等. SPECT/CT诊断髋关节置换术后假体松动价值[J].中华实用诊断与治疗杂志,2014,28(7):707-708.
[25] Seifert WW,Westcott VC. A method for the study of wear particles in lubricating oil[J]. Wear,1972,21(1):27-42.
[26] Mears DC,Hanley EN,Rutkowski R,et al. Ferrographic analysis of wear particles in arthroplastic joints[J]. J Biomed Mater Res,1978,12(6):867-875.
[27] Mendel K, Eliaz N, Benhar I, et al. Magnetic isolation of particles suspended in synovial fluid for diagnostics of natural joint chondropathies[J]. Acta Biomater,2010,6(11):4430-4438.
[28] Hakshur K,Benhar I,Bar-Ziv Y,et al. The effect of hyaluronan injections into human knees on the number of bone and cartilage wear particles captured by bio-ferrography[J]. Acta Biomater,2011,7(2):848-857.
[29]牛舜,朱庆生.生物磁谱分析技术在关节疾病方面的应用前景[J/CD].中华临床医师杂志(电子版),2012,6(2):429-431.
[30] Meyer DM,Tillinghast A,Hanumara NC,et al. Bio-ferrography to capture and separate polyethylene wear debris from hip simulator fluid and compared with conventional filter method[J]. J Tribol,2006,128(2):436-441.
[31] Elsner JJ,Mezape Y,Hakshur K,et al. Wear rate evaluation of a novel polycarbonate-urethane cushion form bearing for artificial hip joints[J]. Acta Biomater,2010,6(12):4698-4707.
[32] Evans CH,Mears DC,Stanitski CL. Ferrographic analysis of wear in human joints. Evaluation by comparison with arthroscopic examination of symptomatic knees[J]. J Bone Joint Surg Br,1982,64(5):572-578.
[2]牛舜,孔令擘,杨重飞,等.阿仑膦酸钠局部释放对假体周围骨溶解的抑制作用[J].中华创伤骨科杂志,2009,11(11):1052-1057.
[3] Niu S, Cao X, Zhang Y, et al. The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debrisinduced peri-implant high bone turnover[J]. J Surg Res,2013,179(1):e107-e115.
[4]吕丹,孙明林.人工髋关节置换后假体无菌性松动的因素及其防治[J].中国组织工程研究与临床康复,2009,13(13):2553-2556.
[5]魏慧,田京.人工关节无菌性松动的早期诊断[J].中国组织工程研究与临床康复,2011,15(4):709-713.
[6]翁习生,翟吉良,林进,等.初次全髋关节置换术后5年以上随访结果[J/CD].中华关节外科杂志(电子版),2011,05(5):561-566.
[7] Lee YH,Park KK,Song HT,et al. Metal artefact reduction in gemstone spectral imaging dual-energy CT with and without metal artefact reduction software[J]. Eur Radiol,2012,22(6):1331-1340.
[8] Van Slambrouck K,Nuyts J. Metal artifact reduction in computed tomography using local models in an image block-iterative scheme[J]. Med Phys,2012,39(11):7080-7093.
[9] Garcia-Cimbrelo E, Tapia M, Martin-Hervas C. Multislice computed tomography for evaluating acetabular defects in revision THA[J]. Clin Orthop Relat Res,2007,463(463):138-143.
[10] Sofka CM. Optimizing techniques for musculoskeletal imaging of the postoperative patient[J]. Radiol Clin North Am,2006,44(3):323-329.
[11] Granchi D,Amato I,Battistelli L,et al. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles[J]. Biomaterials,2005,26(15):2371-2379.
[12] L@hdeoja T,Pajarinen J,Kouri VP,et al. Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals?[J]. J Orthop Res,2010,28(2):184-190.
[13] Crotti TN,Smith MD,Findlay DM,et al. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss:expression of receptor activator NFkappaB,RANK ligand and osteoprotegerin[J]. Biomaterials,2004,25(4):565-573.
[14] Koulouvaris P,Ly K,Ivashkiv LB,et al. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis[J]. J Orthop Res,2008,26(1):106-116.
[15] Granchi D, Pellacani A, Spina M, et al. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis[J]. J Bone Joint Surg Am,2006,88(7):1501-1509.
[16] Savarino L,Granchi D,Cenni E,et al. Systemic cross-linked Nterminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty[J]. J Bone Joint Surg Br,2005,87(4):571-576.
[17] Kauther MD,Zimmermann C,Bachmann H,et al. Biochemical markers of particle induced osteolysis in C57BL/6 mice[J]. Clin Chem Lab Med,2010,48(11):1641-1646.
[18] Streich NA,Gotterbarm T,Jung M,et al. Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty[J]. Int Orthop,2009,33(1):77-82.
[19] Landgraeber S,L`er F,Heep H,et al. Tartrate-resistant acid phosphatase 5b and C-terminal telopeptides of type I collagen as markers for diagnosis of aseptic loosening after total hip replacement[J]. Arch Orthop Trauma Surg,2010,130(4):441-445.
[20] Hundrif-Haspl Z,Pecina M,Haspl M,et al. Plasma cytokines as markers of aseptic prosthesis loosening[J]. Clin Orthop Relat Res,2006,453(453):299-304.
[21] Shanbhag AS, Kaufman AM, Hayata K, et al. Assessing osteolysis with use of high-throughput protein chips[J]. J Bone Joint Surg Am,2007,89(5):1081-1089.
[22] Reinartz P,Mumme T,Hermanns B,et al. Radionuclide imaging of the painful hip arthroplasty:positron-emission tomography versus triple-phase bone scanning[J]. J Bone Joint Surg Br,2005,87(4):465-470.
[23] Mayer-Wagner S,Mayer W,Maegerlein S,et al. Use of 18FFDG-PET in the diagnosis of endoprosthetic loosening of knee and hip implants[J]. Arch Orthop Trauma Surg,2010,130(10):1231-1238.
[24]贾宇东,刘又文,张晓东,等. SPECT/CT诊断髋关节置换术后假体松动价值[J].中华实用诊断与治疗杂志,2014,28(7):707-708.
[25] Seifert WW,Westcott VC. A method for the study of wear particles in lubricating oil[J]. Wear,1972,21(1):27-42.
[26] Mears DC,Hanley EN,Rutkowski R,et al. Ferrographic analysis of wear particles in arthroplastic joints[J]. J Biomed Mater Res,1978,12(6):867-875.
[27] Mendel K, Eliaz N, Benhar I, et al. Magnetic isolation of particles suspended in synovial fluid for diagnostics of natural joint chondropathies[J]. Acta Biomater,2010,6(11):4430-4438.
[28] Hakshur K,Benhar I,Bar-Ziv Y,et al. The effect of hyaluronan injections into human knees on the number of bone and cartilage wear particles captured by bio-ferrography[J]. Acta Biomater,2011,7(2):848-857.
[29]牛舜,朱庆生.生物磁谱分析技术在关节疾病方面的应用前景[J/CD].中华临床医师杂志(电子版),2012,6(2):429-431.
[30] Meyer DM,Tillinghast A,Hanumara NC,et al. Bio-ferrography to capture and separate polyethylene wear debris from hip simulator fluid and compared with conventional filter method[J]. J Tribol,2006,128(2):436-441.
[31] Elsner JJ,Mezape Y,Hakshur K,et al. Wear rate evaluation of a novel polycarbonate-urethane cushion form bearing for artificial hip joints[J]. Acta Biomater,2010,6(12):4698-4707.
[32] Evans CH,Mears DC,Stanitski CL. Ferrographic analysis of wear in human joints. Evaluation by comparison with arthroscopic examination of symptomatic knees[J]. J Bone Joint Surg Br,1982,64(5):572-578.